Add-on Acquisition • Life Science

Stada Acquires Lobsor Pharmaceuticals

On October 2, 2020, Stada acquired life science company Lobsor Pharmaceuticals

Acquisition Context

This is Stada’s 6th transaction in the Life Science sector.
This is Stada’s 1st transaction in Sweden.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	October 2, 2020
Target	Lobsor Pharmaceuticals
Sector	Life Science
Buyer(s)	Stada
Deal Type	Add-on Acquisition

Target Company

Lobsor Pharmaceuticals

Uppsala, Sweden

Lobsor Pharmaceuticals is a specialty pharmaceutical company focusing on innovative, proprietary technologies and drug formulations. Lobsor Pharmaceuticals was founded in 2013 and is based in Uppsala, Sweden.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Stada

Bad Vilbel, Germany

Category	Company
Founded	1895
Sector	Life Science
Employees	10,435
Revenue	2.3B EUR (2018)

DESCRIPTION

Stada is a developer and marketer of active pharmaceutical ingredients for the health care and pharmaceutical markets worldwide. Stada was founded in 1895 and is based in Bad Vilbel, Germany.

Deal Context for Buyer	#
Overall	11 of 11
Sector: Life Science	6 of 6
Type: Add-on Acquisition	8 of 8
Country: Sweden	1 of 1
Year: 2020	2 of 2

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2020-02-24	GlaxoSmithKline - 15 Consumer Healthcare Brands United Kingdom GlaxoSmithKline plc's 15 Consumer Healthcare Brands develops and manufactures consumer healthcare products.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2020-02-24

GlaxoSmithKline - 15 Consumer Healthcare Brands

United Kingdom

GlaxoSmithKline plc's 15 Consumer Healthcare Brands develops and manufactures consumer healthcare products.

Buy

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Sweden M&A - 2020 M&A